Europa Point-of-Care-Marktprognose für molekulare Diagnostik bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Produkten und Dienstleistungen (Assays und Kits, Instrumente sowie Dienstleistungen und Software), Technologie (PCR, isotherme Nukleinsäureamplifikationstechnologie (INAAT), und andere Technologien), Anwendung (Infektionskrankheiten, Onkologie, Hämatologie, pränatale Tests, Endokrinologie und andere Anwendungen), Endbenutzer (Krankenhäuser und Kliniken, Diagnoselabore, Forschungs- und akademische Institute und andere)

Markteinführung

Point-of-Care-Molekulardiagnostik umfasst tragbare Geräte sowie Tests und Tests ; Kits zur Erkennung und Diagnose von Krankheiten in menschlichen Proben wie Rachenabstrich, Blut, Serum und Stuhl. Die molekulare Diagnostik verlagert sich von zentralisierten Laboren hin zu dezentralen molekularen Tests am Behandlungsort. Aufgrund seiner Einfachheit, Bequemlichkeit, schnellen Bearbeitungszeit und dem Potenzial, die Patientenergebnisse zu verbessern, gewinnt POCT schnell an Bedeutung.

Darüber hinaus wächst die Nachfrage nach spezifischen, verbrauchenden Virusnachweismethoden Es wird erwartet, dass weniger Zeit für eine rechtzeitige Infektionskontrolle das Marktwachstum im Prognosezeitraum ankurbeln wird.

In Europa sind derzeit Großbritannien und Russland die am stärksten von der COVID-Krise betroffenen Länder -19-Pandemie, gefolgt von Frankreich, Spanien, Italien und Deutschland. Die Umsetzung drastischer Maßnahmen und Reisebeschränkungen, einschließlich der Schließung der Grenzen, wirkte sich insbesondere im ersten Halbjahr 2020 auf den Import und Export von Produkten aus. Die kontinuierliche Ausbreitung der Krankheit hat daher zu einer erhöhten Nachfrage nach fortschrittlichen Diagnoselösungen in Europa geführt Förderung der Einführung von Point-of-Care-Molekulardiagnostik-Kits. Darüber hinaus fördern ununterbrochene Investitionen und Geschäftsaktivitäten von Branchenakteuren auch das Wachstum des Marktes für Point-of-Care-Molekulardiagnostik. Im Jahr 2020 genehmigte die Europäische Arzneimittel-Agentur (EMA) etwa 97 Arzneimittel zur Marktzulassung, davon 39 neuartige Arzneimittel. Im Oktober 2020 führte Eurofins PCR-basierte COVID-19-Diagnosetests mit der Möglichkeit zur Selbstentnahme zu Hause auf dem europäischen Markt ein. Im Januar 2020 kündigte die Kommission der Europäischen Union (EU) einen Notruf an, bei dem sie 55,64 Millionen US-Dollar an 18 Forschungsprojekte vergab. Drei dieser Projekte erhalten insgesamt 7,39 Millionen US-Dollar für die Entwicklung wirksamer, schneller Point-of-Care-Diagnostika.

Marktübersicht und Dynamik

Der europäische Markt für molekulare Point-of-Care-Diagnostik wird bis 2028 voraussichtlich 1.524,4 Millionen US-Dollar erreichen, gegenüber 653,5 Millionen US-Dollar im Jahr Schätzungen zufolge wird der Markt von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 12,9 % wachsen. Der Aufstieg vernetzter Unterhaltungselektronikgeräte hat ganze Wirtschaftszweige verändert, darunter auch das Gesundheitswesen. Patienten und Verbraucher passen ihre Interaktionen mit medizinischen Produkten und Produkten von POC an. Dienstleistungen aufgrund der Verbreitung mobiler Geräte. Darüber hinaus verändern Verbraucher mit der Verbreitung vernetzter Geräte die Art und Weise, wie sie ihre Gesundheit verwalten und kontrollieren. Daher entwickeln Hersteller benutzerfreundliche, handliche und erschwingliche POC-Molekulardiagnostikgeräte für Nicht-Laborumgebungen, um der steigenden Verbrauchernachfrage gerecht zu werden. Aufgrund der sich schnell entwickelnden Technologielandschaft und der zunehmenden Verbreitung von Smartphones und vernetzten Geräten werden molekulare Diagnose- und Überwachungsgeräte für POC voraussichtlich in Zukunft in Wohngebieten in Volkswirtschaften mit niedrigem und mittlerem Einkommen alltäglich werden.

Wichtige Marktsegmente

In Bezug auf Produkt & Im Bereich der Dienstleistungen hatte das Segment „Assays und Kits“ im Jahr 2020 den größten Anteil am europäischen Point-of-Care-Molekulardiagnostik-Markt. In Bezug auf die Technologie hatte das PCR-Segment den größten Anteil am europäischen Point-of-Care-Molekulardiagnostik-Markt im Jahr 2020. In Bezug auf die Anwendung hatte das Segment Infektionskrankheiten im Jahr 2020 den größten Anteil am Markt für molekulare Point-of-Care-Diagnostik in Europa. In Bezug auf den Endverbraucher hatte das Segment Diagnoselabore den größten Anteil am Europa-Punkt -of-Care-Markt für molekulare Diagnostik im Jahr 2020.

Wichtige Quellen und Unternehmen aufgeführt

Einige wichtige primäre und sekundäre Quellen, auf die bei der Erstellung dieses Berichts über den Point-of-Care-Molekulardiagnostik-Markt in Europa Bezug genommen wird, sind Unternehmenswebsites, Jahresberichte, Finanzberichte, nationale Regierungsdokumente und statistische Datenbanken. unter anderen. Zu den wichtigsten im Bericht aufgeführten Unternehmen gehören bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation und Bio-Rad Laboratories, Inc.

Bericht über Kaufgründe

Um die europäische Marktlandschaft für Point-of-Care-Molekulardiagnostik zu verstehen und Marktsegmente zu identifizieren, die wahrscheinlich eine starke Rendite garantieren
Um die sich ständig verändernde Marktlandschaft zu verstehen und im Wettbewerb vorne zu bleiben
Um Fusionen und Übernahmen sowie Partnerschaftsabkommen im Europe Point effizient zu planen -of-Care Molecular Diagnostics-Markt durch Identifizierung von Segmenten mit den vielversprechendsten wahrscheinlichen Verkäufen
Um fundierte Geschäftsentscheidungen auf der Grundlage einer einfühlsamen und umfassenden Analyse der Marktleistung verschiedener Segmente zu treffen
Um eine Marktumsatzprognose für den europäischen Point-of-Care-Molekulardiagnostik-Markt basierend auf verschiedenen Segmenten für den Zeitraum 2021–2028 zu erhalten

< p>Marktsegmentierung für molekulare Point-of-Care-Diagnostik in Europa

nach Produkt & Dienstleistungen

Assays und Kits
Instrumente
Dienste und Software

Nach Technologie

PCR
Isothermale Nukleinsäureamplifikationstechnologie (INAAT)
Andere Technologien

Nach Anwendung

Vom Endbenutzer

Krankenhäuser und Kliniken
Diagnose Labore
Forschungs- und akademische Institute
Andere

< span>Nach Land

Europa

• Deutschland

• UK

• Frankreich

• Spanien

• Italien

• Restliches Europa

Erwähnte Unternehmen

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2 Europe Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3 Europe Point-of-Care Molecular Diagnostics Market – By Application

1.3.4 Europe Point-of-Care Molecular Diagnostics Market – By End User

1.3.5 Europe Point-of-Care Molecular Diagnostics Market– By Geography

2. Europe Point-of-Care Molecular Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe – PEST Analysis

4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 Pricing Pressures owing to Reimbursement Cuts

5.3 Market Opportunities

5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4 Future Trends

5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market– Europe Analysis

6.1 Europe Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1 Overview

7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3 Assays and Kits

7.3.1 Overview

7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Services and Software

7.5.1 Overview

7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1 Overview

8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3 PCR

8.3.1 Overview

8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1 Overview

8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1 Overview

9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3 Infectious Disease

9.3.1 Overview

9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hematology

9.5.1 Overview

9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Prenatal Testing

9.6.1 Overview

9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Endocrinology

9.7.1 Overview

9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1 Overview

10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Laboratories

10.4.1 Overview

10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Research and Academic Institutes

10.5.1 Overview

10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11. Europe Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1 Europe: Point-of-Care Molecular Diagnostics Market

11.1.1 Overview

11.1.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

11.1.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

11.1.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

11.1.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

11.1.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

11.1.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERIDIAN BIOSCIENCE, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Enzo Biochem Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Biocartis

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Quidel Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Danaher

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 BIO-RAD LABORATORIES INC.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 binx health, inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 2. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 3. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028(US$ Million)

Table 4. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 5. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 6. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 7. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 9. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 10. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 11. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 13. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 15. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 16. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 17. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 22. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 23. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 24. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 25. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 26. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 29. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 30. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 31. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2. Europe Point-of-Care Molecular Diagnostics Market Overview

Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in Europe Point-of-Care Molecular Diagnostics Market

Figure 4. UK to Show Significant Growth During Forecast Period

Figure 5. Europe Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6. Europe PEST Analysis

Figure 7. Europe Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

Figure 29. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 30. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

Figure 31. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 32. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 33. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 35. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 36. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 37. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe

Figure 38. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Point-of-Care molecular diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Europe Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000